Risk factors and analysis of long-term headache in sporadic vestibular schwannoma: a multicenter cross-sectional study

• Published in: Journal of neurosurgery Vol. 123; no. 5; p. 1276
• Main Authors: Carlson, Matthew L, Tveiten, Øystein Vesterli, Driscoll, Colin L, Boes, Christopher J, Sullan, Molly J, Goplen, Frederik K, Lund-Johansen, Morten, Link, Michael J
• Format: Journal Article
• Language: English
• Published: United States 01.11.2015
• Subjects: Aged; Anxiety - psychology; Cross-Sectional Studies; Depression - psychology; Disability Evaluation; Female; Headache - etiology; Humans; Male; Microsurgery; Middle Aged; Neuroma, Acoustic - complications; Neuroma, Acoustic - pathology; Neuroma, Acoustic - surgery; Neurosurgical Procedures; Prognosis; Radiosurgery; Risk Factors; Treatment Outcome; Watchful Waiting; IQR = interquartile range; HADS = Hospital Anxiety and Depression Scale; pain; CPA = cerebellopontine angle; HRQOL = health-related quality of life; SRS = stereotactic radiosurgery; microsurgery; ICHD-II = International Classification of Headache Disorders, Second Edition; oncology; stereotactic radiosurgery; acoustic neuroma; cephalgia; PANQOL = Penn Acoustic Neuroma Quality of Life; cerebellopontine angle; Gamma Knife radiosurgery; headache; HDI = Henry Ford Hospital Headache Disability Inventory; VS = vestibular schwannoma; vestibular schwannoma
• ISSN: 1933-0693
• DOI: 10.3171/2014.12.JNS142109

The primary goals of this study were: 1) to examine the influence of disease and treatment on headache in patients with sporadic vestibular schwannoma (VS); and 2) to identify clinical predictors of long-term headache disability. This was a cross-sectional observational study with international multicenter enrollment. Patients included those with primary sporadic <3-cm VS and a separate group of general population control subjects without tumors. Interventions included a postal survey incorporating the Headache Disability Inventory (HDI), the Hospital Anxiety and Depression Scale, and a VS symptom questionnaire. The main outcome measures were univariate and multivariable associations with HDI total score. The overall survey response rate was 79%. Data from 538 patients with VS were analyzed. The mean age at time of survey was 64 years, 56% of patients were female, and the average duration between treatment and survey was 7.7 years. Twenty-seven percent of patients received microsurgery, 46% stereotactic radiosurgery, and 28% observation. Patients with VS who were managed with observation were more than twice as likely to have severe headache disability compared with 103 control subjects without VS. When accounting for baseline differences, there was no statistically significant difference in HDI outcome between treatment modalities at time of survey. Similarly, among the microsurgery cohort, the long-term risk of severe headache disability was not different between surgical approaches. Multivariable regression demonstrated that younger age, greater anxiety and depression, and a preexisting diagnosis of headache were the primary predictors of severe long-term headache disability, while tumor size and treatment modality had little influence. At a mean of almost 8 years following treatment, approximately half of patients with VS experience headaches of varying frequency and severity. Patient-driven factors including age, sex, mental health, and preexisting headache syndrome are the strongest predictors of long-term severe headache disability. Tumor size and treatment modality have less impact. These data may assist with patient counseling regarding long-term expectations following diagnosis and treatment.